Gisela Pogátsa-Murray

Author

Also Known As

Anna Wieczorek, Birgit Steppich, G Pogatsa-Murray, G Pogátsa-Murray, Gisela Pogatsa-Murray, Gisela Pogátsa-Murray, Gisela Pogátsa-Murray, Silja Rüdiger

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Technical University of Munich Deutsches Herzzentrum der Charité Deutsches Herzzentrum München Klinikum rechts der Isar Ludwig-Maximilians-Universität München

About

Gisela Pogátsa-Murray is an author at Technical University of Munich specializing in medicine, thrombosis, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	668
2	Emergency Medicine	3	3	175
3	Cell Biology	2	2	290
4	Public Health	1	1	34
5	Cellular Physiology	1	1	253

Gisela Pogátsa-Murray

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel Nicolas von Beckerath, Dirk Taubert, Gisela Pogátsa-Murray, Circulation	2005	626
Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes Franz‐Josef Neumann, Adnan Kastrati, Gisela Pogátsa-Murray, JAMA	2003	462
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis Meinrad Gawaz, Korbinian Brand, Timm Dickfeld, Atherosclerosis InflammationThrombosisInterleukin-1-dependent MechanismEndothelial CellsAdhesive Properties	2000	253
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days Nicolas von Beckerath, Adnan Kastrati, Anna Wieczorek, European Heart Journal	2007	204
Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy Adnan Kastrati, Nicolas von Beckerath, Alexander Joost, Circulation	2004	195
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Circulation	2004	166
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial Franz‐Josef Neumann, Adnan Kastrati, Thomas Miethke, The Lancet Percutaneous Coronary InterventionNeointima ProliferationAntibioticsClinical EpidemiologyChlamydia Pneumoniae Infection	2001	123
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting Franz‐Josef Neumann, Willibald Hochholzer, Gisela Pogátsa-Murray, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletCoronary Artery Disease	2001	86
Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy Suzanne Fateh‐Moghadam, Wolfgang Bocksch, Andreas Ruf, Circulation	2000	79
Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement Andreas Ruf, F. Neumann, Gisela Pogátsa-Murray, Thrombosis and Haemostasis	1998	76

Page 1